Call for stronger action comes on warning of growing risk the virus will evolve to spread more easily between humans
Pharma groups say higher levy will stifle growth of life sciences
Convoluted NHS systems mean some patients are left without support for months, as demand for services rises
People treated with amycretin lost up to 22% of their body weight after 36 weeks
The San Francisco-based start-up plans to get its first drug into trials this year
Spotify founder’s body-scanning start-up valued at $1.7bn in new funding round
Sector knocked by disappointing sales, an unexpected trial result and questions about the size of the market
Study finds jump of 65% between 2012-2022 and suggests thousands may not be getting needed specialist care
Routes that really set the pace in great global cities
The free running event turns 21 this year — and its continuing global expansion makes it an excellent way to see another side of a city
Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis
Richard Blakeway says toxic metal is going ‘undetected’ and should be treated as seriously as asbestos
Kestra Medical Technologies and Heartflow make non-invasive cardiac tests for patients with heart conditions
Could the decline of face-to-face interaction tie together several modern mysteries?
Luxury bellwether regains crown as drugmaker slips on concerns it will have to cut weight loss medication prices in US
Advances in brain-computer interfaces enable paralysed users to feel objects in a realistic way via a robotic limb
About 70% of nurses in the UK are delivering care in ‘inappropriate’ settings, says union
How an eminent scientist’s career coincided with a remarkable transformation
An electric masseuse, sleep aid, sports smartwatch and more
Surge in chronic disease triggers search for ways to improve treatment access for millions of people at risk
Government says there are no cases in Britain as it vows to do ‘whatever it takes’ to protect farmers
Sales figures for Mounjaro and Zepbound spook investors in world’s biggest drugmaker
Stock plunge of 22% comes as vaccine maker grapples with shrinking market for Covid jabs
Non-EU countries announce curbs after outbreak of viral disease in eastern state
How ‘hand balancing’ became a modern obsession
